A carregar...

Immunotherapy Trials for Type 1 Diabetes: The Contribution of George Eisenbarth

Type 1 diabetes (T1D) results from the autoimmune destruction of pancreatic β-cells, and as such it should respond to immunotherapy. George Eisenbarth gave many significant contributions to this field. He has been involved at some level in most immunotherapy trials during the past three decades. He...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Skyler, Jay S., Pugliese, Alberto
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3676656/
https://ncbi.nlm.nih.gov/pubmed/23786294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2013.0107
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!